Cidara Therapeutics, Inc.
New Filing
CIK: 0001610618·Biotechnology·DELAWARE·Filed: May 6, 2024
Total Offering
$240,000,000
Amount Sold
$240,000,000
Investors
7
First Sale
Apr 24, 2024
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Jeffrey Stein, Ph.D. | Related Person |
| Daniel D. Burgess | Related Person |
| Theodore R. Schroeder | Related Person |
| Bonnie Bassler, Ph.D. | Related Person |
| Carin Canale-Theakston | Related Person |
| James Merson, Ph.D. | Related Person |
| Ryan Spencer | Related Person |
| Laura Tadvalkar, Ph.D. | Related Person |
| Taylor Sandison, M.D. | Related Person |
| Preetam Shah, Ph.D. | Related Person |
| Leslie Tari, Ph.D. | Related Person |
| Shane Ward | Related Person |
Company
SEC Filing
0001610618-24-000069
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free